Using Social Media to Recruit for Cancer Clinical Trials
Alicia Staley, survivor and patient advocacy manager of Cure Forward, discusses the potential use of social media to recruit for clinical trials for new cancer treatment.
Alicia Staley, survivor and patient advocacy manager of Cure Forward, discusses the potential use of social media to recruit for clinical trials for new cancer treatment.
Staley explains that the peer-to-peer network that social media offers would be a great tool to connect patients and researchers across the nation and get more enrollment in clinical trials.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More
